This result supports the biphasic interpretation and indicates that MDA-MB-468 is indeed a multi-driver cancer cell line, dependent on Akt and EGFR signaling, and that combination targeted therapy strategy would likely be an effective strategy for a cancer with a similar mechanism. The gene discussed is AKT1; the disease is cancer.